The Relationship Between Infectivity of Serum from Hepatitis B Virus Carriers, Antiviral Therapy, and Integrated Hepatitis B Virus DNA

This publication has 31 references indexed in Scilit:

• Antiviral Treatment of Chronic Hepatitis B Virus Infection: Infectious Virus Cannot Be Detected in Patient Serum after Permanent Responses to Treatment
  Hepatology, 1982
• Integration of Hepatitis B Virus DNA into the Genome of Liver Cells in Chronic Liver Disease and Hepatocellular Carcinoma
  New England Journal of Medicine, 1981
• DETECTION OF HEPATITIS B VIRUS DNA IN LIVER AND SERUM: A DIRECT APPRAISAL OF THE CHRONIC CARRIER STATE
  The Lancet, 1981
• The risk of hepatitis B transmission from staff to patients in hemodialysis units--an overrated problem?
  Hepatology, 1981
• State of hepatitis B virus DNA in hepatocytes of patients with hepatitis B surface antigen-positive and -negative liver diseases.
  Proceedings of the National Academy of Sciences, 1981
• Antiviral Treatment of Chronic Hepatitis B Virus Infection. I. Changes in Viral Markers with Interferon Combined with Adenine Arabinoside
  The Journal of Infectious Diseases, 1981
• Adenine arabinoside therapy in HBsAg-positive chronic liver disease: A controlled study
  Gastroenterology, 1981
• DOUBLE-BLIND STUDY OF LEUCOCYTE INTERFERON ADMINISTRATION IN CHRONIC HBsAg-POSITIVE HEPATITIS
  The Lancet, 1980
• Health-Care Workers Positive for Hepatitis B Surface Antigen
  New England Journal of Medicine, 1975
• NATURAL HISTORY OF HEPATITIS-ASSOCIATED ANTIGEN-POSITIVE CHRONIC LIVER DISEASE
  The Lancet, 1972